Background The -93G>A (rs1800734) polymorphism located in the promoter of mismatch repair gene, MLH1, has been identified as a low-penetrance variant for cancer risk. Many published studies have evaluated the association between the MLH1 -93G>A polymorphism and colorectal cancer (CRC) risk. However, the results remain conflicting rather than conclusive. Objective The aim of this study was to assess the association between the MLH1 -93G>A polymorphism and the risk of CRC. Methods To derive a more precise estimation of the association, a meta-analysis of six studies (17,791 cases and 13,782 controls) was performed. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the strength of the association. Four of these published studies were performed on subjects of known microsatellite instability (MSI) status. An additional analysis including 742 cases and 10,895 controls was used to assess the association between the MLH1 -93G>A polymorphism and the risk of MSI-CRC. Results The overall results indicated that the variant genotypes were associated with a significantly increased risk of CRC (AG versus GG: OR = 1.06, 95% CI = 1.01–1.11; AA/AG versus GG: OR = 1.06, 95% CI = 1.01–1.11). This increased risk was also found during stratified analysis of MSI status (AA versus GG: OR = 2.52, 95% CI = 1.94–3.28; AG versus GG: OR = 1.29, 95% CI = 1.10–1.52; AA/AG versus GG: OR = 1.45, 95% CI = 1.24–1.68; AA versus AG/GG: OR = 2.29, 95% CI = 1.78–2.96). Egger’s test did not show any evidence of publication bias. Conclusion Our results suggest that the MLH1 -93G>A polymorphism may contribute to individual susceptibility to CRC and act as a risk factor for MSI-CRC.
References
[1]
Garcia-Albeniz X, Chan AT (2011) Aspirin for the prevention of colorectal cancer. Best Pract Res Clin Gastroenterol 25: 461–72.
[2]
Malekzadeh R, Bishehsari F, Mahdavinia M, Ansari R (2009) Epidemiology and molecular genetics of colorectal cancer in iran: a review. Arch Iran Med 12: 161–9.
[3]
de la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4: 769–80.
[4]
Kunkel TA, Erie DA (2005) DNA mismatch repair. Annu Rev Biochem 74: 681–710.
[5]
Jean M, Pelletier J, Hilpert M, Belzile F, Kunze R (1999) Isolation and characterization of AtMLH1, a MutL homologue from Arabidopsis thaliana. Mol Gen Genet 262: 633–42.
[6]
Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, et al. (2009) Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut 58: 661–7.
[7]
Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368: 258–61.
[8]
Peltomaki P, Vasen H (2004) Mutations associated with HNPCC predisposition – Update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 20: 269–76.
[9]
Tomlinson IP, Houlston RS, Montgomery GW, Sieber OM, Dunlop MG (2012) Investigation of the effects of DNA repair gene polymorphisms on the risk of colorectal cancer. Mutagenesis 27: 219–23.
[10]
Arita M, Zhong X, Min Z, Hemmi H, Shimatake H (2003) Multiple sites required for expression in 5′-flanking region of the hMLH1 gene. Gene 306: 57–65.
[11]
Ito EYY, Iwahashi Y, Suzuki Y, Nagasaki H, AkiyamaY, et al (1999) A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun 256: 488–494.
[12]
Handoll HH (2006) Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil 87: 875.
[13]
Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719–48.
[14]
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177–88.
[15]
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629–34.
[16]
Chen H, Taylor NP, Sotamaa KM, Mutch DG, Powell MA, et al. (2007) Evidence for heritable predisposition to epigenetic silencing of MLH1. Int J Cancer 120: 1684–8.
[17]
Allan JM, Shorto J, Adlard J, Bury J, Coggins R, et al. (2008) MLH1 -93G>A promoter polymorphism and risk of mismatch repair deficient colorectal cancer. Int J Cancer 123: 2456–9.
[18]
Koessler T, Oestergaard MZ, Song H, Tyrer J, Perkins B, et al. (2008) Common variants in mismatch repair genes and risk of colorectal cancer. Gut 57: 1097–101.
[19]
Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, et al. (2007) MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. J Natl Cancer Inst 99: 463–74.
[20]
Samowitz WS, Curtin K, Wolff RK, Albertsen H, Sweeney C, et al. (2008) The MLH1 -93G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes Chromosomes Cancer 47: 835–44.
[21]
Tulupova E, Kumar R, Hanova M, Slyskova J, Pardini B, et al. (2008) Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer? Mutat Res 648: 40–5.
[22]
Whiffin N, Broderick P, Lubbe SJ, Pittman AM, Penegar S, et al. (2011) MLH1-93G>A is a risk factor for MSI colorectal cancer. Carcinogenesis 32: 1157–61.
[23]
Mohrenweiser HW, Jones IM (1998) Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat Res 400: 15–24.
[24]
Knudson AG (1997) Hereditary predisposition to cancer. Ann N Y Acad Sci 833: 58–67.
[25]
Ito E, Yanagisawa Y, Iwahashi Y, Suzuki Y, Nagasaki H, et al. (1999) A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun 256: 488–94.
[26]
Perera S, Mrkonjic M, Rawson JB, Bapat B (2011) Functional effects of the MLH1-93G>A polymorphism on MLH1/EPM2AIP1 promoter activity. Oncol Rep 25: 809–15.
[27]
Goldsborough AS, Kornberg TB (1996) Reduction of transcription by homologue asynapsis in Drosophila imaginal discs. Nature 381: 807–10.
[28]
Pan XM, Yang WZ, Xu GH, Bai P, Qin HJ, et al. (2011) The association between MLH1 -93G>A polymorphism of DNA mismatch repair and cancer susceptibility: a meta-analysis. Mutagenesis 26: 667–73.
[29]
Xu JL, Yin ZQ, Huang MD, Wang XF, Gao W, et al. (2012) MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies. Asian Pac J Cancer Prev 13: 901–7.
